CSX vs TERN · P/E 19, rev $14.09B vs $6.12B cap
CSX Corporation (CSX) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CSX and TERN stock pages for the full models.
Not investment advice.